Compare Wegovy vs Mounjaro Availability & Key Differences
What's Better Wegovy or Mounjaro for UK Patients: Current Stock Status
When comparing what's better between Wegovy or Mounjaro, availability often determines the practical choice. EverydayMeds maintains consistent stock of both treatments through established supply agreements with Novo Nordisk and Eli Lilly respectively. Our Wegovy inventory includes all five dose strengths from 0.25mg starter pens through to 2.4mg maintenance doses, eliminating the waitlist anxiety that has affected other suppliers. Mounjaro stock levels remain equally robust across the 2.5mg to 15mg dose range.
The question of what's better Wegovy or Mounjaro extends beyond simple availability to encompass storage flexibility—a crucial factor for UK patients. Wegovy pens maintain stability for up to 6 weeks at room temperature once removed from refrigeration, compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy particularly suitable for frequent travellers or those with limited refrigeration access. Both treatments require clinical assessment and ongoing prescriber supervision as prescription-only medicines.
Wegovy vs Mounjaro Pricing: Complete UK Cost Comparison
Understanding what's better Wegovy or Mounjaro requires examining the complete cost structure for UK patients. Wegovy pricing at EverydayMeds starts with the 0.25mg dose at £79.99, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg) to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout to reach these final prices, while returning patients use code DOSE25. Bundle options like our Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 provide convenient multi-month supply.
Mounjaro pricing follows a different structure reflecting its unique dose escalation schedule and dual-hormone mechanism. When evaluating what's better Wegovy or Mounjaro from a cost perspective, consider the total treatment duration and maintenance phase requirements. Both treatments represent long-term commitments alongside reduced-calorie diets and increased physical activity. The prescriber assessment fee and delivery costs remain consistent regardless of treatment choice, ensuring transparent pricing across both options.
Clinical Evidence: What's Better Wegovy or Mounjaro Based on Trial Data
Determining what's better Wegovy or Mounjaro requires understanding their distinct clinical profiles without direct head-to-head comparison. Wegovy's evidence base centres on the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with Wegovy treatment.
Mounjaro's clinical foundation rests on the SURMOUNT studies investigating tirzepatide's dual GLP-1/GIP mechanism. Both treatment approaches have shown efficacy in clinical settings, but individual responses vary significantly. The question of what's better Wegovy or Mounjaro ultimately depends on patient-specific factors including medical history, tolerability and treatment goals, making prescriber guidance essential for optimal outcomes.
How Wegovy Works: Understanding the GLP-1 Mechanism
When comparing what's better Wegovy or Mounjaro, understanding Wegovy's targeted GLP-1 approach provides crucial context. Semaglutide mimics the natural GLP-1 hormone released by intestinal cells after eating, binding to GLP-1 receptors in the brain's appetite control centres. This mechanism reduces hunger sensations while promoting earlier satiety after smaller meals, supporting portion control efforts. The once-weekly injection schedule maintains consistent hormone levels, avoiding the peaks and troughs associated with daily medications. Wegovy's FlexTouch pen design ensures accurate dosing through the mandatory escalation schedule from 0.25mg starter dose to 2.4mg maintenance level.
Ordering Process: Getting Wegovy or Mounjaro in Stock UK
Accessing either treatment through EverydayMeds follows the same streamlined process regardless of whether you choose Wegovy or Mounjaro. The 3-minute online clinical assessment captures essential medical history, current medications and treatment goals to support prescriber decision-making. Standard prescriber review takes up to 3 working days, with express 24-hour options available for urgent requirements. Once approved, both treatments ship via next-day delivery using temperature-controlled cold-chain logistics to maintain medication stability. GPhC registration #9012878 ensures full regulatory compliance throughout the prescription and dispensing process.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Life
Practical factors often influence what's better Wegovy or Mounjaro for individual lifestyles beyond clinical considerations. Wegovy requires refrigerated storage at 2-8°C before first use but tolerates up to 6 weeks at room temperature below 30°C once removed, providing exceptional travel flexibility. The dose escalation follows a structured 16-week schedule reaching 2.4mg maintenance, with each pen containing 4 doses for monthly convenience. Injection technique uses the familiar FlexTouch pen system with audible click confirmation and automatic needle safety features. Both treatments require injection site rotation and proper disposal of used pens through pharmacy return schemes or approved sharps containers.
What's Better Wegovy or Mounjaro: Supply Chain Reliability UK
Supply consistency distinguishes what's better Wegovy or Mounjaro from a practical UK perspective, particularly given historical shortages affecting weight management treatments. EverydayMeds maintains direct relationships with both Novo Nordisk and Eli Lilly, ensuring reliable stock replenishment independent of parallel import fluctuations. Our Wegovy inventory management system prevents stock-outs through automated reordering based on prescription volume forecasting.
The question what's better Wegovy or Mounjaro becomes academic if preferred treatments remain unavailable when needed for dose escalation or maintenance. Both manufacturers have invested heavily in UK supply chain resilience following previous capacity constraints. EverydayMeds' dual-supplier approach means patients can switch between treatments if supply issues arise, though this requires fresh clinical assessment and prescriber approval.
Making Your Choice: Wegovy vs Mounjaro Expert Guidance
Rather than definitively answering what's better Wegovy or Mounjaro, successful treatment selection requires individualised clinical assessment considering medical history, lifestyle factors and treatment preferences. Both treatments offer proven efficacy when used alongside reduced-calorie diets and increased physical activity as prescription-only medicines. The 6-week room temperature storage advantage may favour Wegovy for travel-intensive lifestyles, while Mounjaro's dual-hormone approach appeals to patients seeking alternative mechanisms. EverydayMeds stock both options with identical service standards including clinical assessment, prescriber review and next-day delivery. Use discount codes FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our competitive pricing. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today with our qualified prescriber team.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
